Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence

Vu T, Wiendl H, Katsuno M, Reddel SW, Howard JF Jr

Neuropsychiatric Disease and Treatment 2023, 19:2639-2655

Published Date: 1 December 2023